文献速递头颈部肿瘤放疗

TNM 8分期对局部晚期口腔鳞癌术后放疗患者的预后判断优于TNM 7

TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
PubMed 文献 · Radiother Oncol · 2021-05-03

该研究回顾性分析了172例接受手术及术后放疗的局部晚期口腔鳞状细胞癌患者,按TNM 7和TNM 8分别分期。TNM 8对总生存和无病生存有显著分层能力,TNM 7则无;多因素分析中TNM 8分期、体能状态和手术切缘阳性是总生存的预后因素,TNM 8 IVB期、淋巴血管侵犯、较年轻年龄和较少吸烟史可预测12个月内早期复发。

要点

  • TNM 8对局部晚期口腔鳞癌术后放疗患者的总生存和无病生存有显著分层,TNM 7无。
  • 多因素分析中TNM 8分期、体能状态和手术切缘阳性是总生存的预后因素。
  • TNM 8 IVB期、淋巴血管侵犯、年龄<60岁和吸烟<10包年是12个月内早期复发的预测因素。

核心结论

  • TNM 8分期在预测局部晚期口腔鳞状细胞癌患者生存方面优于TNM 7分期。
  • 年龄<60岁和吸烟史<10包年是早期疾病复发的风险因素,可能代表口腔鳞癌中的一个独立生物学亚群。

研究设计与样本

  • 回顾性分析2010年1月至2018年12月间接受手术及术后放疗的局部晚期口腔鳞状细胞癌患者资料。
  • 共纳入172例患者,按TNM 7和TNM 8分别分期,采用Kaplan-Meier法估计总生存和无病生存。
  • 进行单因素和多因素分析,评估影响总生存、无病生存及12个月内早期复发的因素。

主要发现

  • 全队列中位随访时间为32个月,存活患者中位随访时间为48个月。
  • TNM 8分期在整个队列中对总生存和无病生存有显著分层,而TNM 7分期无显著分层。
  • 多因素分析中,TNM 8分期、体能状态和手术切缘阳性是总生存的预后因素。
  • 对于12个月内疾病复发,多因素分析显示TNM 8 IVB期、淋巴血管侵犯、较年轻年龄和较少吸烟史是预测因素。

关键数值与推荐

  • TNM 8分期对总生存和无病生存有显著分层能力,TNM 7分期无显著分层能力。
  • 总生存的多因素预后因素包括TNM 8分期、体能状态和手术切缘阳性。
  • 12个月内早期复发的多因素预测因素包括TNM 8 IVB期、淋巴血管侵犯、年龄<60岁和吸烟史<10包年。

临床怎么用

  • 对于局部晚期口腔鳞状细胞癌术后放疗患者,应采用TNM 8分期进行预后评估和分层。
  • 需关注体能状态和手术切缘阳性对总生存的影响,并据此调整随访或治疗策略。
  • 对具有TNM 8 IVB期、淋巴血管侵犯、年龄<60岁或吸烟<10包年等风险因素的患者,应加强早期复发监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess TNM 8 staging in discriminating overall survival (OS) amongst patients with locally advanced oral cavity squamous cell carcinoma (OCSCC) treated with surgery and post-operative radiotherapy (PORT), compared to TNM 7. MATERIAL AND METHODS: Data from OCSCC patients treated with surgery and PORT between January 2010 and December 2018 were reviewed. Demographics, tumour characteristics and treatment response data were collected, and patients staged according to both TNM 7 and TNM 8. OS and disease free survival (DFS) were estimated using the Kaplan Meier method. Univariate and multivariable analyses were conducted for factors affecting OS, DFS and early disease recurrence within 12 months. RESULTS: Overall 172 patients were analyzed. Median follow up was 32 months for all patients and 48 months for surviving patients. TNM 8 staging demonstrated significant stratification of OS and DFS amongst the entire cohort, whereas TNM 7 staging did not. On multivariable analysis, TNM 8 stage, performance status (PS) and a positive surgical margin were prognostic for OS. Looking at disease recurrence within 12 months, TNM 8 stage IVB, presence of lymphovascular invasion (LVSI), younger age and lesser smoking history were predictive factors on multivariable analysis. CONCLUSION: TNM 8 is a good development of its predecessor in terms of predicting survival for patients with locally advanced OCSCC. We have also identified younger age (<60 years) and a smoking history of <10 pack years as risk factors for early disease recurrence, potentially representing a separate biological cohort within OCSCC patients.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Sambasivan K, Sassoon I, Thavaraj S, et al. TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy. Radiother Oncol. 2021. PMID: 33845044. doi:10.1016/j.radonc.2021.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。